D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$315M |
| 2 |
Exxon Mobil
XOM
|
+$312M |
| 3 |
Verizon
VZ
|
+$289M |
| 4 |
Procter & Gamble
PG
|
+$288M |
| 5 |
Pfizer
PFE
|
+$272M |
Top Sells
| 1 |
Tesla
TSLA
|
+$619M |
| 2 |
Biogen
BIIB
|
+$369M |
| 3 |
Amazon
AMZN
|
+$341M |
| 4 |
Netflix
NFLX
|
+$309M |
| 5 |
Emerson Electric
EMR
|
+$306M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Healthcare | 14.5% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 9.56% |
| 5 | Communication Services | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Itaú Unibanco
ITUB
$75.8B
| $17.8M | 0.03% |
5,290,929
+4,083,013
| +338% | +$13.7M |
|
502
Roku
ROKU
$13.9B
| $17.8M | 0.03% |
203,416
+175,793
| +636% | +$15.4M |
|
503
Usana Health Sciences
USNA
$555M
| $17.7M | 0.03% |
306,986
-66,900
| -18% | -$3.86M |
|
504
Unum
UNM
$12.5B
| $17.7M | 0.03% |
1,180,462
-1,049,595
| -47% | -$15.8M |
|
505
Ultragenyx Pharmaceutical
RARE
$3B
| $17.7M | 0.03% |
398,474
+84,306
| +27% | +$3.75M |
|
506
Nice
NICE
$8.78B
| $17.7M | 0.03% |
122,960
+89,754
| +270% | +$12.9M |
|
507
Reinsurance Group of America
RGA
$12.6B
| $17.6M | 0.03% |
209,096
+204,300
| +4,260% | +$17.2M |
|
508
Workiva
WK
$4.23B
| $17.5M | 0.03% |
542,712
+167,067
| +44% | +$5.4M |
|
509
Douglas Emmett
DEI
$2.74B
| $17.5M | 0.03% |
573,893
+501,587
| +694% | +$15.3M |
|
510
East-West Bancorp
EWBC
$14.9B
| $17.5M | 0.03% |
679,593
-201,708
| -23% | -$5.19M |
|
|
GBT
511
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.5M | 0.03% |
341,735
+238,735
| +232% | +$12.2M |
|
512
Aecom
ACM
$16.6B
| $17.4M | 0.03% |
583,569
-75,788
| -11% | -$2.26M |
|
513
Planet Fitness
PLNT
$8.54B
| $17.4M | 0.03% |
357,030
+220,435
| +161% | +$10.7M |
|
514
Broadcom
AVGO
$1.72T
| $17.4M | 0.03% |
732,020
-717,830
| -50% | -$17M |
|
|
UNIT
515
Uniti Group
UNIT
$1.7B
| $17.3M | 0.03% |
2,866,268
-2,109,493
| -42% | -$12.7M |
|
516
OGE Energy
OGE
$8.86B
| $17.3M | 0.03% |
562,119
+400,648
| +248% | +$12.3M |
|
517
Navient
NAVI
$1.3B
| $17.2M | 0.03% |
2,274,828
-339,217
| -13% | -$2.57M |
|
518
Toronto Dominion Bank
TD
$129B
| $17.2M | 0.03% |
405,004
-1,180,291
| -74% | -$50.2M |
|
519
Sleep Number
SNBR
$214M
| $17.2M | 0.03% |
898,730
-169,477
| -16% | -$3.25M |
|
520
Ingredion
INGR
$8.09B
| $17.1M | 0.03% |
226,746
-135,006
| -37% | -$10.2M |
|
521
Progressive
PGR
$144B
| $17.1M | 0.03% |
231,014
-1,747,008
| -88% | -$129M |
|
522
Axon Enterprise
AXON
$58.2B
| $17M | 0.03% |
240,354
-242,092
| -50% | -$17.1M |
|
|
DLPH
523
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $16.9M | 0.03% |
2,102,077
-588,331
| -22% | -$4.74M |
|
524
HDFC Bank
HDB
$180B
| $16.9M | 0.03% |
+439,925
| New | +$16.9M |
|
525
Estee Lauder
EL
$31.7B
| $16.9M | 0.03% |
105,966
+98,028
| +1,235% | +$15.6M |
|